Perceptive Advisors Llc - Portfolio Holdings, AUM (13F, 13G) - Joseph Edelman
Perceptive Advisors LLC Raises Stock Position in Artivion, Inc. (NYSE:AORT) - MarketBeat
Sarepta investor: High drug prices are a good thing
Did Hedge Funds Make The Right Call On Quotient Limited (QTNT) ?
Perceptive Advisors Llc modifies stake in Lyra Therapeutics Inc (NASDAQ:LYRA)
Perceptive Advisors' Neptune Wellness stake grew by 50% in Q3. The cannabis stock is now the hedge fund's #20 position. - WhaleWisdom Alpha
A Sixth Sense For Biotech Has Made Joe Edelman A Hedge Fund Star
Top 10 Stocks Held By Perceptive Advisors LLC - Slide 1 of 10
Perceptive Advisors - Crunchbase Investor Profile & Investments
Institutional Top Ideas Series: Perceptive Advisors | Seeking Alpha
The 41% Man | Institutional Investor
Perceptive Advisors Llc cuts stake in ALBO / Albireo Pharma Inc
Is Athenex, Inc. (ATNX) A Good Stock To Buy?
Insiders Turn Bullish on Athira Pharma; Shares Rise - TipRanks.com
Tegna, First United, Alico, and Other 13D Filings | Barron's
Institutional Top Ideas Series: Perceptive Advisors | Seeking Alpha
Hedge fund Perceptive raises $323M life sciences debt fund | Fierce Biotech
Perceptive Advisors Llc Net Worth (2023) - GuruFocus.com
Institutional Top Ideas Series: Perceptive Advisors | Seeking Alpha
SEC fines Perceptive Advisors $1.5M for 'material misstatements' involving Cayman mutual fund - OffshoreAlert
Institutional Top Ideas Series: Perceptive Advisors | Seeking Alpha
Hedge Fund and Insider Trading News: Kyle Bass, Daniel Och, Bill Ackman, Perceptive Advisors, Schonfeld Strategic Advisors, Coatue Management, Merrimack Pharmaceuticals Inc (MACK), AMC Entertainment Holdings Inc (AMC), and More - Insider
Perceptive Advisors Company Profile: Financings & Team | PitchBook
Perceptive Advisors' Neptune Wellness stake grew by 50% in Q3. The cannabis stock is now the hedge fund's #20 position. - WhaleWisdom Alpha
Outperforming the S&P 500 with 50 Consensus Stock Holdings of 40 Large Hedge Funds | iMarketSignals
Perceptive Advisors Llc modifies stake in Crinetics Pharmaceuticals Inc (NASDAQ:CRNX)
